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SUMMARY
Rotaviral associated disease of infants in the UK is seasonal and infection in adults not
uncommon but the relationship between these has been little explored. Adult sera collected
monthly for one year from routine hospital samples were screened for the presence of anti-group
A rotavirus immunoglobulin M class antibodies as a marker of recent infection. Anti-rotavirus
IgM was seen in all age groups throughout the year with little obvious seasonal variation in
the distribution of antibody levels. IgM concentrations and the proportion seropositive above
a threshold both increased with age with high concentrations consistently observed in the elderly.
Results suggest either high infection rates of rotavirus in adults, irrespective of seasonal disease
incidence in infants, IgM persistence or IgM cross-reactivity. These results support recent
evidence of diﬀerences between infant and adult rotavirus epidemiology and highlight the need
for more extensive surveys to investigate age and time related infection and transmission of
rotavirus.
INTRODUCTION
Rotaviruses are responsible for 30–40% of reported
infant diarrhoea worldwide with high mortality in
developing countries and signiﬁcant morbidity and
hospitalizations in industrialized nations [1]. Typi-
cally, most severe rotaviral disease occurs upon pri-
mary infection, usually in infants less than 5 years old,
although this does not induce complete protective
immunity. Repeat infections are common but gener-
ally less severe in outcome [2, 3] due to development
of a partially eﬀective immune response. Rotaviral
disease is also common amongst the elderly, particu-
larly through outbreaks in residential care [4–8].
Although there have been many studies investi-
gating the epidemiology of disease and repeat infec-
tion (symptomatic and asymptomatic) in children
[2, 3, 9–13] less attention has focused on infection
and disease in other age groups. Studies which have
investigated rotaviral infection in older age groups
have long suggested that infection rates could be high,
especially in case contacts [14, 15]. Adult rotaviral in-
fection has been measured using viral antigen in stools
[16, 17] and through serology using IgM as a marker
of recent or current infection [18–21]. However, these
studies did not consider seasonal variation which is
normally considerable in most geographical settings
except the tropics [22].
In the UK, rotaviral disease in infants is highly
seasonal with incidence peaking, currently, around
April although cases occur year round [23]. The mech-
anisms generating seasonality are not fully under-
stood and are the subject of debate [24, 25]. A number
of factors may be involved, e.g. climatic factors [26],
age-speciﬁc mixing patterns, rotaviral strain diver-
sity and the dynamics of host susceptibility [27]. A
recent study of clinical diarrhoea in adults in Japan
[17] found that patterns of disease did not mirror
the winter seasonality seen in infants and that peaks
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of infection occurred at diﬀerent time points from
year to year. These results suggest that the factors
driving seasonality in infants are not having the same
inﬂuence on adults where infection is clearly common
and appears more temporally unpredictable. This
study has investigated age-speciﬁc and seasonal levels
of anti-group A rotaviral IgM in sera from a predomi-
nantly adult population in the UK.
METHODS
Sample collection
Sera were collected from the Department of Clinical
Chemistry, Birmingham Heartlands Hospital, be-
tween September 1997 and October 1998, from those
collected routinely for diagnostic screening from
in-patients and patients of local GPs. Around 150
samples were collected at the end of each calendar
month and selected randomly from samples about to
be discarded (normally around 800 per day). Samples
were taken anonymously with only sex, year of birth
and reason for sample collection being recorded
(when completed). It was noted when a sample had
been collected from a patient with symptoms which
could possibly be attributed to rotavirus infection, i.e.
diarrhoea and/or abdominal pain, or respiratory
infection. Ethical permission to conduct the study
was obtained from the Heartlands Hospital Ethics
Committee. Sera were pre-diluted 1 in 10 into 50:50
PBS/glycerol on the day of collection to avoid the
detrimental eﬀects of freeze-thawing on IgM anti-
body. Prediluted sera were then stored at x25 xC
until use but were initially screened within 1 week.
Antigen
Rotavirus strains UKtc (bovine, serotype 6) and
SA11 (simian, serotype 3) were grown in BSC-1 cells
until maximum CPE. Virus was harvested and freeze/
thawed three times before centrifugation to remove
cell debris. The supernatant was used as antigen and
uninfected cells, similarly treated, were used as con-
trol antigen. Puriﬁed UKtc was produced using a
caesium chloride gradient centrifugation based on
published methods [28].
Rotavirus IgM capture-immunoassay
Anti-rotavirus IgM was detected using a capture
EIA technique based on those previously described
[21, 29]. Brieﬂy, 96 well microtitre plates (Immunlon
II, Dynatech) were coated with 50 ml of optimally
diluted rabbit polyclonal anti-human IgM (Dako) in
carbonate buﬀer (pH 9.6) overnight at 4 xC. Plates
were then blocked with 100 ml 4% skim milk powder
(SMP) in phosphate-buﬀered saline (PBS, pH 7.2)
for 1 h at 37 xC. Plates were washed three times
with PBS plus 0.05% Tween 20 (Tw) (Sigma). Fifty
microliters of sera, diluted to 1 in 200 in PBS-
SMP-Tw, were added for 2 h at 37 xC followed, after
washing, by 50 ml rotaviral antigen (or control anti-
gen), in PBS-SMP-Tw (2 h 37 xC). After three washes,
50 ml anti-rotavirus group A horseradish peroxidase
conjugate (Cambridge Biotech) was added for 1 h at
37 xC. Colour was developed, after further washing,
using OPD/H2O2 substrate (Dako, UK) followed by
2 M H2SO4 and read at 492 nm (630 nm reference).
Each plate contained serial dilutions of a high titre
anti-rotavirus IgM positive of pooled adult (UK) sera
to allow for plate to plate variation and to standard-
ize test samples using linear regression. The standard
was given an arbitrary antibody unitage and the
results obtained with test sera are presented as log
antibody units.
A number of controls were performed to investigate
possible non-speciﬁc reactions and variability within
the assay. A number of sera (n=360) were re-screened
on diﬀerent plates on diﬀerent days to investigate
individual and day to day test variation. Sera were
also screened, as above, on plates with no capture
antibody or no antigen (carbonate buﬀer and PBS-
SMP-Tw20 only) or using control antigen. Sera
were also screened using two other capture antibodies
(aﬃnity-puriﬁed goat polyclonal anti-human IgM and
mouse monoclonal anti-human IgM (Sigma, UK))
as well as comparing UKtc antigen with SA11 and
puriﬁed UKtc antigen (pUKtc) under the same assay
conditions as above. All reagent concentrations were
optimized by checkerboard assay before use.
Sera (n=48) were also screened by capture assay
for IgM following depletion of IgG using protein A
sepharose (Sigma, UK). Protein A sepharose was
reconstituted in 50 mM Tris buﬀer (pH 8). Sera were
pre-incubated with four times the volume of sephar-
ose agar in Tris buﬀer to give a ﬁnal serum dilution
of 1 in 200 and incubated for 2 h at room tempera-
ture on a blood rotor then centrifuged for 5 min at
1000 rpm. Sera with and without IgG depletion were
treated identically (Tris buﬀer alone replacing
sepharose) and screened in adjacent wells on the same
plate. Sera (n=100) of all ages (18–93 years, x=65.5)
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and with a variety of rotaviral IgM concentrations
(49% >1.5 log units ; 18% >2 log units) were also
screened for rheumatoid factor (Serodia-RA, Fuji-
rebio Inc, Japan). Samples positive or indeterminate
for rheumatoid factor were re-screened.
Results were analysed using QuattroPro (Corel,
1997) and MatLab (v6, The MathWorks, Inc). Given
that IgM is generally short-lived it would be expected
that the distribution of anti-rotaviral IgM levels
within the population would follow a highly skewed
distribution with the majority of those seropositive
having very low concentrations and only a few (most
recently infected) having higher concentrations. Thus,
the use of known IgM seropositives from clinical
samples (likely to be high titre) would not be of
value in community-based studies for evaluation of
a threshold for IgM detection. Therefore, the true
IgM-positive prevalence cannot be calculated. The
empirical cut-oﬀ chosen to classify seropositive and
eronegative sera in this study was based on the
assumption that seronegative samples would be nor-
mally distributed and that the distribution of sero-
positive samples would be skewed with the majority
having low concentrations and merging with the
distribution of seronegatives. A cut-oﬀ estimate was
made by taking a step-wise approach to calculating
the skewness of the total frequency distribution
(Fig. 1). The IgM antibody concentration where the
skewness equalled zero (0.91 log antibody) was as-
sumed to represent the upper limit of the distribution
of seronegatives. The mean log antibody concen-
tration of this assumed seronegative population plus
three standard deviations was used as the cut-oﬀ
for seropositivity (equal to 0.9968 log units) and
for comparison of age and time-related trends. This
cut-oﬀ translated into an optical density of around
0.15–0.18 with the absorbance range of seropositives
increasing to around 1.0 maximally.
RESULTS
In total, 1768 sera were collected between November
1997 and October 1998 (Table 1). It was noted, where
possible, if the sample had been collected from a
patient showing any symptoms of possible rotavirus
infection, i.e. abdominal pain or diarrhoea (2.1%).
It was assumed that this percentage was reﬂected
amongst those samples where no reason for collection
was given (14.9%) resulting in an adjusted value of
2.4%. The majority of samples (97.6%), therefore,
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Fig. 1. Frequency distribution of anti-group A rotavirus IgM antibody concentrations for the total population (n=1768).
The inset graph depicts the changing value of the skewness of the distribution used to estimate the cut-oﬀ for seropositive
samples.
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were collected for reasons other than from possible
gastrointestinal infectious disease. Of 100 samples
screened for rheumatoid factor, 6 were positive and 3
indeterminate upon re-screening.
Repeat screening of serum samples for anti-rota-
viral IgM showed signiﬁcant correlation (n=360,
Pearson correlation=0.943, P<0.001). Signiﬁcant
correlations were also seen when alternative capture
antibodies were used with crude Uktc antigen (rabbit
versus goat polyclonal anti-IgM, n=88, r=0.98, P<
0.001; rabbit polyclonal versus mouse monoclonal
anti-IgM, n=88, r=0.901, P<0.001). Comparison of
antigens also gave signiﬁcant correlations (rabbit
polyclonal+SA11 vs. pUktc n=48, r=0.878, P<
0.01; mouse monoclonal+Uktc vs. pUKtc n=96,
r=0.977, P<0.01). No non-speciﬁc reaction occurred
when capture antibody or antigen was omitted nor
when control antigen was used. Signiﬁcant corre-
lations in rotaviral IgM levels were seen between
samples with or without prior removal of IgG (mean
depletion of IgG 82%) (n=48, r=0.969, P<0.01).
Using the estimated cut-oﬀ of 0.9968 log units,
prevalence was seen to vary between months from
20.4% inMarch to 11% and 10% in July and August
respectively. No seasonal trend in mean antibody
levels was observed (Table 1). Prevalence appeared
to increase with age overall and this was signiﬁcant
(test for trend, x2=6.93, P<0.01) for all months
combined (Table 2). Mean antibody concentrations,
in those over 30 years of age, were also seen to
increase with age. The variance in antibody concen-
tration in those individuals under 30 years and,
more particularly, in those over 80 years, was high
(Table 2). IgM levels for individuals of all ages in
each month (Fig. 2) revealed that high antibody
levels were commonly seen in the very elderly.
Table 1. Monthly variation in rotavirus IgM prevalence
Month
1997–8
Sample
size
Sex*
Mean age
(range)
% reporting
symptoms#
Rotavirus
IgM
prevalence$
Mean rotavirus
IgM concentration
(S.E.)·Male Female
November 149 78 65 56.8 (2–98) 2.5 0.154 1.38 (0.084)
December 148 63 74 58.9 (1–95) 2.9 0.189 1.40 (0.085)
January 149 64 74 61.6 (12–98) 2.8 0.188 1.22 (0.044)
February 148 73 71 63.4 (12–95) 2.5 0.162 1.38 (0.122)
March 142 62 69 55.9 (13–88) 1.6 0.204 1.41 (0.097)
April 147 58 82 57.4 (12–95) 0.9 0.136 1.36 (0.106)
May 148 54 86 57.9 (8–96) 3.2 0.176 1.53 (0.111)
June 147 65 77 60.3 (16–97) 2.6 0.177 1.35 (0.080)
July 144 65 76 60.9 (1–97) 0.7 0.111 1.31 (0.056)
August 150 64 86 60.4 (3–97) 1.6 0.100 1.44 (0.099)
September 149 73 71 56.6 (13–97) 3.9 0.161 1.24 (0.049)
October 147 81 62 57.8 (14–98) 3.7 0.136 1.27 (0.067)
Total 1768 800 893 59.0 2.4 0.158 1.36 (0.026)
* Sex not recorded for 4.2% of samples.
# Recorded as abdominal pain or diarrhoea.
$ Seropositive deﬁned as>1.0 log antibody units.
· Mean concentrations of only those deﬁned as seropositive (as above).
Table 2. Age-speciﬁc rotavirus IgM seroprevalence
Age group
(years)
Sample
size
(mean age)
Rotavirus
IgM
prevalence
Mean rotavirus
IgM concentration
(S.E.)*
0–9 7 (3.3) 0.14 —
10–19 34 (16.8) 0.117 1.35 (0.104)
20–29 151 (25.1) 0.105
30–39 168 (34.4) 0.137 1.21 (0.043)
40–49 197 (44.7) 0.132 1.30 (0.059)
50–59 244 (54.9) 0.159 1.33 (0.057)
60–69 317 (64.8) 0.145 1.36 (0.051)
70–79 378 (74.3) 0.195 1.37 (0.050)
80–89 226 (83.9) 0.176 1.47 (0.089)
90–99 46 (93.7) 0.152
Total 1768 (59.0) 0.156 1.36 (0.025)
* Single seropositive for 0–9 age group; 10–29 and 80–99
year age groups pooled. Variances for these age groups were
0.215; 0.041; 0.088; 0.127; 0.117; 0.184; 0.367 respectively.
Also see footnotes in Table 1.
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Increasing the cut-oﬀ for seropositivity to a highly
conservative value of 1.5 log units did not change the
seasonal nor age-speciﬁc seroprevalence trends.
DISCUSSION
Primary infection with rotavirus often leads to severe
disease and incomplete immunity to re-infection but
subsequent infections are usually less clinically severe
[1]. Re-infection in adults can still result in clinical
disease, perhaps due to waning immunity or some
complex immune-dynamics of heterotypic infection,
but infection can often be asymptomatic [30]. The
objective of this study, using IgM as a marker of cur-
rent or recent infection, was to estimate how much
infection may be occurring in adults and whether this
correlates with seasonal patterns of clinical disease
seen in younger age groups.
The assay used in this study to measure IgM was
sensitive and robust and most sources of possible
non-speciﬁc reactions were eliminated. A serum
dilution of 1 in 200, although high for an IgM assay,
gave reduced background absorbances than lower
dilutions. There was no relationship between adults
designated IgM seropositive and those reporting
possible symptoms of rotavirus infection. The pres-
ence of RF or IgG did not appear to aﬀect results.
Although puriﬁed rotaviral antigen was used, cross-
reaction with other antigens cannot be ruled out and
may require further investigation. The criteria with
which to characterize individual sera as positive or
negative for anti-rotaviral IgM will have a profound
inﬂuence on the resulting seroprevalence. The cut-oﬀ
chosen in this study relies on the fact that negative
samples will be normally distributed and that, stat-
istically, any sample with an antibody concentration
which is greater than the mean of negative samples
plus three standard deviations could be deﬁned
as seropositive with 99.7% certainty. Further studies
should be conducted to improve the sensitivity and
speciﬁcity of the capture assay and investigate the
dynamics of IgM responses and their correlation
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Fig. 2. Scatter plots of anti-rotavirus IgM concentrations by age for each month showing the estimated cut-oﬀ for sero-
positivity (0.9968 log units).
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with virus shedding in semi-immune individuals. Such
studies have been done in infants [31] but not, to
our knowledge, in adults. The use of IgM for popu-
lation-based seroepidemiological studies would be
an invaluable tool for understanding transmission
dynamics of viral diseases where repeat, mild or sub-
clinical infection is common. Such data could be used
to estimate the rate of infection (l), an important
epidemiological parameter for the theoretical design
of control programmes [32], by using IgM titre as a
marker of time since infection.
A high prevalence of speciﬁc IgM was seen in all
months (ranging from 11–20%). Although the lowest
prevalences were seen in July and August there
was no clear seasonal seroprevalence patterns which
would correlate with known patterns of disease in
infants (peaking around April). The dynamics of IgM
responses to rotavirus infection in sera from adults
following repeat infection are not well understood
and are likely to be inﬂuenced by a number of factors
such as age, the number of previous infections, time
since last infection and history of serotype-speciﬁc
infection (homotypic or heterotypic infection). Per-
sistence of IgM has been observed for a number
of viral infections not only where virus persists,
e.g. CMV [33] but also where infection is cleared
e.g. rubella [34]. The high prevalence of rotavirus
IgM seen in a previous study [19] was also explained
by possible persistence of antibody although this
was not apparent in other studies of infants [31] or
adults [20].
It may be that low levels of chronic infection persist
in partially immune individuals and such infections
are tolerated. Persistence of infection has been in-
vestigated in infants where shedding of rotavirus
following severe disease was shown to have a broad
distribution [35] with 30% shedding for up to 57 days.
There was no correlation with age but the age range
was limited and sample sizes small. It is not known
for how long adults might shed virus following in-
fection but asymptomatic rates of 5% have been
reported [17], which may be a result of persistence.
The observation of increased antibody levels with
age, with the highest concentrations commonly seen
in the very elderly may simply reﬂect the known in-
creased susceptibility of this age group and who, in
this study, may largely come from residential care.
A recent study in Sweden reported 7–13% of clinical
rotavirus infection occurred in the elderly [36] and
the elderly have been suggested as a reservoir for
infection [37]. It should be noted that our samples
were collected from a biased section of the normal
adult community, i.e. hospital in-patients or those
reporting to local GPs with a variety of ailments.
Nosocomial infection with rotavirus has been well
documented and is known to be a major route of
transmission. Therefore, care has to be taken in
extrapolating these results to the normal healthy
adult community. However, the high prevalence of
antibody seen in all months suggests that a larger
community-based study is required to investigate
how much infection (as opposed to just disease)
maybe occurring in diﬀerent age groups throughout
the year. However, the collection of large numbers
of serum samples from infants, where seasonality in
IgM prevalence should be observed, is extremely dif-
ﬁcult. These studies should not only be investigated
serologically but also through the detection of the
viral genome using RT-PCR which could also be
genotype-speciﬁc [38–40]. Signiﬁcant diﬀerences in
the distribution of serotypes causing clinical disease
in adults versus children have been observed in the
UK [40] possibly reﬂecting diﬀerent epidemiological
transmission processes.
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